Faragli Alessandro, Herrmann Alexander, Cvetkovic Mina, Perna Simone, Khorsheed Eman, Lo Muzio Francesco Paolo, La Porta Edoardo, Fassina Lorenzo, Günther Anna-Marie, Oetvoes Jens, Düngen Hans-Dirk, Alogna Alessio
Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum Der Charité, Campus Virchow-Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
Clin Res Cardiol. 2024 Nov 4. doi: 10.1007/s00392-024-02571-7.
Hospital re-admissions in heart failure (HF) patients are mostly caused by an acute exacerbation of their chronic congestion. Bioimpedance analysis (BIA) has emerged as a promising non-invasive method to assess the volume status in HF. However, its correlation with clinically assessed volume status and its prognostic value in the acute intra-hospital setting remains uncertain.
In this single-center observational study, patients (n = 49) admitted to the cardiology ward for acute decompensated HF (ADHF) underwent a daily BIA-derived volume status assessment. Median hospital stay was 7 (4-10) days. Twenty patients (40%) reached the composite endpoint of cardiovascular mortality or re-hospitalization for HF over 6 months. Patients at discharge displayed improved NYHA class, lower body weight, plasma and blood volume, as well as lower NT-proBNP levels compared to the admission. Compared to patients with total body water (TBW) less than or equal to that predicted by body weight, those with higher relative TBW levels had elevated NT-proBNP and E/e´ (both p < 0.05) at discharge. In the Cox multivariate regression analysis, the BIA-derived delta TBW between admission and discharge showed a 23% risk reduction for each unit increase (HR = 0.776; CI 0.67-0.89; p = 0.0006). In line with this finding, TBW at admission had the highest prediction importance of the combined endpoint for a subgroup of high-risk HF patients (n = 35) in a neural network analysis.
In ADHF patients, BIA-derived TBW is associated with the increased risk of HF hospitalization or cardiovascular death over 6 months. The role of BIA for prognostic stratification merits further investigation.
心力衰竭(HF)患者再次入院大多是由慢性充血急性加重所致。生物电阻抗分析(BIA)已成为一种有前景的非侵入性方法,用于评估HF患者的容量状态。然而,其与临床评估的容量状态的相关性及其在急性院内环境中的预后价值仍不确定。
在这项单中心观察性研究中,因急性失代偿性心力衰竭(ADHF)入住心内科病房的患者(n = 49)接受了每日基于BIA的容量状态评估。中位住院时间为7(4 - 10)天。20名患者(40%)在6个月内达到了心血管死亡或因HF再次住院的复合终点。与入院时相比,出院时患者的纽约心脏病协会(NYHA)分级改善、体重、血浆和血容量降低,NT - proBNP水平也降低。与全身水(TBW)低于或等于体重预测值的患者相比,相对TBW水平较高的患者出院时NT - proBNP和E/e´升高(均p < 0.05)。在Cox多因素回归分析中,入院和出院之间基于BIA得出的TBW变化量每增加1个单位,风险降低23%(HR = 0.776;CI 0.67 - 0.89;p = 0.0006)。与此发现一致,在神经网络分析中,入院时的TBW对高危HF患者亚组(n = 35)的联合终点具有最高的预测重要性。
在ADHF患者中,基于BIA得出的TBW与6个月内HF住院或心血管死亡风险增加相关。BIA在预后分层中的作用值得进一步研究。